News
FDA expands access to MDMA as therapeutic treatment for PTSD
The FDA's Expanded Access program will allow 50 patients to enroll in MDMA-assisted psychotherapy.
The FDA's Expanded Access program will allow 50 patients to enroll in MDMA-assisted psychotherapy.
Trump is backing a purported miracle drug in efforts to combat the staggering veteran suicide rate.
The FDA has extended approval to Abilify MyCite, the first digitized pill to be outfitted with a sensor that can track a patient's pill ingestion schedule.
The FDA has given MDMA the okay to advance to Phase II trials in PTSD treatment, labeling the drug as a breakthrough in the study of PTSD remedy.
New research reveals MDMA-aided psychotherapy is able to ease symptoms synonymous with PTSD.
FDA is strongly considering full authorization of MDMA-assisted psychotherapy in 2021.